John Eriksson

The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling (2013)

Biochemical Pharmacology

Peuhu E, Paul P, Remes M, Holmbom T, Eklund P, Sjoholm R, Eriksson JE

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis (2008)

Journal of Immunology Research

Andrey Mikhailov, Alice Sokolovskaya, Gennady G Yegutkin, Hanne Amdahl, Anne West, Hideo Yagita, Riitta Lahesmaa, Linda F Thompson, Sirpa Jalkanen, Dmitry Blokhin, John E Eriksson

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Fas costimulation of naive CD4 T cells is controlled by NF-kappa B signaling and caspase activity (2006)

Journal of Leukocyte Biology

Maksimow Mikael, Söderström Thomas S., Jalkanen Sirpa, Eriksson John E., Hänninen Arno

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Publications

Sort by:

The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling (2013)

CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis (2008)

Fas costimulation of naive CD4 T cells is controlled by NF-kappa B signaling and caspase activity (2006)